Literature DB >> 8215526

Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91).

R Booy1, S A Hodgson, M P Slack, E C Anderson, R T Mayon-White, E R Moxon.   

Abstract

For a seven year period (1985-91) clinical and epidemiological data were prospectively collected on children aged < 10 years with microbiologically confirmed invasive Haemophilus influenzae type b infection in the Oxford region to study the epidemiology of the disease and determine the potential impact of early primary immunisation in infants. Computer records of primary immunisations given to these cases were retrospectively analysed and, where necessary, hospital and general practitioner records were searched to determine the immunisation history. Over the seven year period, 416 cases of invasive H influenzae type b disease were reported. Widescale immunisation against H influenzae type b began in 1991 as part of a regional trial. The estimated annual incidence for invasive disease between 1985 and 1990 was 35.5 cases per 100,000 children aged less than 5 years; for H influenzae type b meningitis it was 25.1 per 100,000 children aged less than 5 years. The cumulative risks for invasive disease and meningitis by the fifth birthday were one in 560 and one in 800 respectively. The majority of disease (71%) occurred in children less than 2 years of age with the peak monthly incidences at 6 and 7 months of age. The overall mortality was 4.3% and 50% of these deaths occurred suddenly. Most (91%) of the children had received at least one primary immunisation against diphtheria, tetanus, and pertussis before H influenzae type b infection and there was only one case of parental refusal of immunisation. None had received H influenzae type b immunisation. Given a vaccine uptake of 90% by 5 months of age it is estimated that at least 82% of the H influenzae type b infections could have been prevented. Extrapolated nationally, 1150 cases of infection and 50 deaths could be prevented each year by routine primary immunisation.

Entities:  

Mesh:

Year:  1993        PMID: 8215526      PMCID: PMC1029463          DOI: 10.1136/adc.69.2.225

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.

Authors:  J Ward; G Brenneman; G W Letson; W L Heyward
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

2.  Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region.

Authors:  R Booy; E R Moxon; J A MacFarlane; R T Mayon-White; M P Slack
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

3.  Haemophilus influenzae type b disease in the Oxford region.

Authors:  G Tudor-Williams; J Frankland; D Isaacs; R T Mayon-White; J A MacFarlane; M P Slack; E Anderson; D G Rees; E R Moxon
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

4.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

5.  Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Authors:  S B Black; H R Shinefield; B Fireman; R Hiatt; M Polen; E Vittinghoff
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

6.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

7.  Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

Authors:  J Eskola; H Peltola; A K Takala; H Käyhty; M Hakulinen; V Karanko; E Kela; P Rekola; P R Rönnberg; J S Samuelson
Journal:  N Engl J Med       Date:  1987-09-17       Impact factor: 91.245

8.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

Authors:  A K Takala; J Eskola; M Leinonen; H Käyhty; A Nissinen; E Pekkanen; P H Mäkelä
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

9.  Epidemiology of Haemophilus influenzae type b invasive disease in Wales.

Authors:  A J Howard; K T Dunkin; J M Musser; S R Palmer
Journal:  BMJ       Date:  1991-08-24

10.  Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors.

Authors:  S L Cochi; D W Fleming; A W Hightower; K Limpakarnjanarat; R R Facklam; J D Smith; R K Sikes; C V Broome
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

View more
  16 in total

1.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

Authors:  J McVernon; P D R Johnson; A J Pollard; M P E Slack; E R Moxon
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

2.  Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease.

Authors:  P Clarke; P J Powell; D Goldblatt; M J Robinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

3.  Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Authors:  Ulla Kou Griffiths; Andrew Clark; Rana Hajjeh
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

4.  Haemophilus influenzae serotype a as the causative agent of a pediatric upper extremity infection.

Authors:  Michael Bezuhly; Joel S Fish
Journal:  Hand (N Y)       Date:  2011-11-09

5.  Haemophilus influenzae vaccine: maximizing uptake.

Authors:  R Booy; S C Marriage; H Davies
Journal:  Br J Gen Pract       Date:  1995-10       Impact factor: 5.386

Review 6.  Meningitis.

Authors:  H P Lambert
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

7.  Incidence of invasive Haemophilus influenzae type b disease in Italian children.

Authors:  A E Tozzi; S Salmaso; M L Ciofi degli Atti; P Panei; A Anemona; G Scuderi; S G Wassilak
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

8.  Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2).

Authors:  E C Anderson; N T Begg; S C Crawshaw; R M Hargreaves; A J Howard; M P Slack
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania.

Authors:  V Luca; B D Gessner; C Luca; T Turcu; S Rugina; C Rugina; M Ilie; E Novakova; C Vlasich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-26       Impact factor: 3.267

Review 10.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.